# UPMC Enterprises

> UPMC Enterprises is UPMC’s innovation, commercialization and venture-investment arm. Its translational-sciences work supports life-sciences companies; it participated in Estuary Biotherapeutics’ October 2026 Series A. Sources: https://enterprises.upmc.com/about/ and https://estuarybio.com/news/estuary-series-a

## Profile

- **Stage-based planning range:** $100K–$1M
- **Check-size evidence basis:** estimated
- **Founded:** N/A
- **Headquarters:** N/A
- **AUM:** N/A
- **Rounds they lead:** N/A
- **Rounds they invest:** N/A
- **Last verified:** 2026-10-17

## Links

- [Website](https://enterprises.upmc.com/)

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** October 17, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/fund/upmc-enterprises